Explore more publications!

Tajikistan Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.

Press releases published on November 10, 2025

Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Collaborations
CareCloud Announces Plan to Pay Double Monthly Dividends on its Series B Preferred Stock Beginning in January 2026
Intermap Announces Date for Third Quarter Earnings
Datavault AI Files Lawsuit Against Wolfpack Research and Its Founder Dan David
Black Friday just got bigger: Hostinger raises discounts to help everyone start online
BTDUex Global Mainnet Goes Live, Ushering in a New Era of Digital Asset Autonomy
rabbitholes.fi Announces Presale on Gempad and Public ICO Dates
Applied Digital Announces Proposed Offering of $2.35 Billion of Senior Secured Notes
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Bluejay Therapeutics’ Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response and up to 82% Combined Endpoint of Virologic Response and ALT Normalization at Week 48 in Phase 2 Study in Chronic Hepatitis D (CHD)
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
AirBoss Defense Group Received Order CBRN Products Valued at $8.1M
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions